SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: dino who wrote (5878)10/14/1998 12:11:00 PM
From: Tokyo VD  Read Replies (2) | Respond to of 7041
 
Dino,

You may be right about the variety of factors that are limiting Viagra sales, but it may speak volumes of the patient market for these drugs.

Of the $141 million in Viagra sales in the most recent quarter, only $115 milllion were domestic. That is ominous for both Pfizer and others who want to participate in the market.

Good luck.

Tokyo



To: dino who wrote (5878)10/14/1998 12:34:00 PM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
LOL, Dino! It's rather more likely to break 10 than 100, IMO, but neither will occur today. The market's basically still spinning.

Do you mean an advanced oral version of Viagra, that will reduct side effects and increase efficacy, will reduce Viagra's future sales potential?

The market is just not as big as was originally thought, no matter how you cut it.

--Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News